Vidal C, Quintela A G, Millán I, Gude F, Cuervas-Mons V
Department of Medicine, Autonomous University, Madrid, Spain.
Clin Exp Allergy. 1994 Jun;24(6):540-8. doi: 10.1111/j.1365-2222.1994.tb00951.x.
Hypergammaglobulinemia is a well-known feature of liver cirrhosis, but studies on serum IgE in this setting are limited. The present study evaluates serum IgE concentration in a group of cirrhotic patients and examines their relationship with aetiological, clinical and analytical parameters (including liver function tests and hepatic phagocytic activity). The presence of specific IgE against common dietary antigens was also investigated. Total serum IgE was determined by enzyme immunoassay (EIA) in 52 cirrhotics (27 alcoholic and 25 non-alcoholic, including eight virus B and seven virus C-related cirrhosis, three primary biliary cirrhosis, three cryptogenic, three haemochromatosis and one Wilson's disease) and 34 healthy subjects (used as controls). Serum IgE (IU/ml) in controls was not significantly different from that of cirrhotic patients (median 42, range 2-726 vs median 86, range 2- > 1000, respectively) (P = NS). However, serum IgE among alcoholics (median 199, range 19- > 1000) was higher than that of controls (P < 0.001), virus B-related cirrhotics (median 25, range 3- > 1000) (P < 0.05), virus C-related cirrhotics (median 47, range 2-170) (P < 0.05), or non-alcoholic cirrhotics as a whole (median 23, range 2- > 1000) (P < 0.01). High IgE levels (> or = 170 IU/ml) were detected in 55.5% of alcoholics compared with only 12% of non-alcoholic cirrhotics (P < 0.01). Moreover, IgE levels were very high (> 1000 IU/ml) in six patients of the alcoholic group (22.2%) compared with only one non-alcoholic patient (4%).(ABSTRACT TRUNCATED AT 250 WORDS)
高球蛋白血症是肝硬化的一个众所周知的特征,但关于肝硬化患者血清IgE的研究有限。本研究评估了一组肝硬化患者的血清IgE浓度,并探讨了其与病因、临床及分析参数(包括肝功能检查和肝脏吞噬活性)之间的关系。还研究了针对常见饮食抗原的特异性IgE的存在情况。采用酶免疫测定法(EIA)测定了52例肝硬化患者(27例酒精性肝硬化和25例非酒精性肝硬化,包括8例乙型病毒性肝炎和7例丙型病毒性肝炎相关肝硬化、3例原发性胆汁性肝硬化、3例隐源性肝硬化、3例血色素沉着症和1例威尔逊病)及34名健康受试者(作为对照)的总血清IgE。对照组血清IgE(IU/ml)与肝硬化患者相比无显著差异(中位数分别为42,范围2 - 726和中位数86,范围2 - >1000)(P =无显著性差异)。然而,酒精性肝硬化患者血清IgE(中位数199,范围19 - >1000)高于对照组(P < 0.001)、乙型病毒性肝炎相关肝硬化患者(中位数25,范围3 - >1000)(P < 0.05)、丙型病毒性肝炎相关肝硬化患者(中位数47,范围2 - 170)(P < 0.05)或总体非酒精性肝硬化患者(中位数23,范围2 - >1000)(P < 0.01)。55.5%的酒精性肝硬化患者检测到高IgE水平(≥170 IU/ml),而非酒精性肝硬化患者仅为12%(P < 0.01)。此外,酒精性肝硬化组有6例患者(22.2%)IgE水平非常高(>1000 IU/ml),而非酒精性肝硬化患者仅有1例(4%)。(摘要截断于250字)